Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics

This publication has 45 references indexed in Scilit:

• Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
  Blood, 2002
• The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
  Blood, 2001
• Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
  British Journal of Haematology, 2000
• The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
  Blood, 1998
• The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis
  British Journal of Haematology, 1997
• Diagnostic and Prognostic Significance of Cytogenetics in Adult Primary Myelodysplastic Syndromes
  Leukemia & Lymphoma, 1996
• Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization
  Blood, 1993
• Combination of classical and interphase cytogenetics to investigate the biology of myeloid disorders: Detection of masked monosomy 7 in AML
  Leukemia Research, 1993
• Application of fluorescence in situ hybridization in hematological disorders
  Cancer Genetics and Cytogenetics, 1992
• Detection of trisomy 8 in hematological disorders by in situ hybridization
  Cytogenetic and Genome Research, 1991